Page 67 - JCBP-2-4

Journal of Clinical and
Basic Psychosomatics Schizophrenia and metabolism

term, randomized, open-label, multicenter, pharmacologic comparison with national estimates from NHANES III.
trial. J Clin Psychiatry. 2020;81:19m12785. Schizophr Res. 2005;80:19-32.
doi: 10.4088/JCP.19m12785 doi: 10.1016/j.schres.2005.07.014
7. Goldfarb M, De Hert M, Detraux J, et al. Severe mental 18. Kay SR, Fiszbein A, Opler LA. The Positive and Negative
illness and cardiovascular disease: JACC state-of-the-art Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull.
review. J Am Coll Cardiol. 2022;80:918-933. 1987;13:261-276.
doi: 10.1016/j.jacc.2022.06.017 doi: 10.1093/schbul/13.2.261
8. Ninkov A, Frank JR, Maggio LA. Bibliometrics: Methods 19. Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of
for studying academic publishing. Perspect Med Educ. antipsychotic drugs in patients with chronic schizophrenia.
2022;11:173-176. N Engl J Med. 2005;353:1209-1223.
doi: 10.1007/s40037-021-00695-4 doi: 10.1056/NEJMoa051688
9. Chen C, Song M. Visualizing a field of research: 20. Allison DB, Mentore JL, Heo M, et al. Antipsychotic-
A methodology of systematic scientometric reviews. PLoS induced weight gain: A comprehensive research synthesis.
One. 2019;14:e0223994. Am J Psychiatry. 1999;156:1686-1696.
doi: 10.1371/journal.pone.0223994 doi: 10.1176/ajp.156.11.1686
10. Wang J, Shahzad F. A Visualized and scientometric analysis of 21. Huhn M, Nikolakopoulou A, Schneider-Thoma J,
health literacy research. Front Public Health. 2021;9:811707. et al. Comparative efficacy and tolerability of 32 oral
antipsychotics for the acute treatment of adults with multi-
doi: 10.3389/fpubh.2021.811707
episode schizophrenia: A systematic review and network
11. Liu X, Zhao S, Tan L, et al. Frontier and hot topics in meta-analysis. Lancet. 2019;394:939-951.
electrochemiluminescence sensing technology based
on CiteSpace bibliometric analysis. Biosens Bioelectron. doi: 10.1016/s0140-6736(19)31135-3
2022;201:113932. 22. Penninx BWJ, Lange SMM. Metabolic syndrome in
psychiatric patients: Overview, mechanisms, and
doi: 10.1016/j.bios.2021.113932
implications. Dialogues Clin Neurosci. 2018;20:63-73.
12. Van Eck NJ, Waltman L. Software survey: VOSviewer, a doi: 10.31887/DCNS.2018.20.1/bpenninx
computer program for bibliometric mapping. Scientometrics.
2010;84:523-538. 23. Pillinger T, McCutcheon RA, Vano L, et al. Comparative
effects of 18 antipsychotics on metabolic function in patients
doi: 10.1007/s11192-009-0146-3
with schizophrenia, predictors of metabolic dysregulation,
13. Huggett S. Journal bibliometrics indicators and citation and association with psychopathology: A systematic review
ethics: A discussion of current issues. Atherosclerosis. and network meta-analysis. Lancet Psychiatry. 2020;7:64-77.
2013;230:275-277.
doi: 10.1016/s2215-0366(19)30416-x
doi: 10.1016/j.atherosclerosis.2013.07.051
24. Li M, Weng PF. A Bibliometrics analysis on academic
14. Chen MY, Zhang Q, Liu YF, et al. Schizophrenia and influence of Chinese journal of integrated traditional and
oxidative stress from the perspective of bibliometric analysis. Western medicine. Chin J Integr Med. 2021;27:148-152.
Front Psychiatry. 2023;14:1145409.
doi: 10.1007/s11655-020-3434-7
doi: 10.3389/fpsyt.2023.1145409
25. Deng Z, Wang H, Chen Z, Wang T. Bibliometric analysis of
15. Sun HL, Bai W, Li XH, et al. Schizophrenia and inflammation Dendritic Epidermal T Cell (DETC) research from 1983 to
research: A bibliometric analysis. Front Immunol. 2019. Front Immunol. 2020;11:259.
2022;13:907851.
doi: 10.3389/fimmu.2020.00259
doi: 10.3389/fimmu.2022.907851
26. Vancampfort D, Stubbs B, Mitchell AJ, et al. Risk of metabolic
16. Gao Q, Zhang C, Wang J, et al. The top 100 highly cited syndrome and its components in people with schizophrenia
articles on osteoporosis from 1990 to 2019: A bibliometric and related psychotic disorders, bipolar disorder and major
and visualized analysis. Arch Osteoporos. 2020;15:144. depressive disorder: A systematic review and meta-analysis.
World Psychiatry. 2015;14:339-347.
doi: 10.1007/s11657-020-0705-z
17. McEvoy JP, Meyer JM, Goff DC, et al. Prevalence of the doi: 10.1002/wps.20252
metabolic syndrome in patients with schizophrenia: 27. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and
Baseline results from the Clinical Antipsychotic Trials of management of the metabolic syndrome: An American
Intervention Effectiveness (CATIE) schizophrenia trial and Heart Association/National Heart, Lung, and Blood Institute

Volume 2 Issue 4 (2024) 11 doi: 10.36922/jcbp.4238